Family history of malignant tumor is a predictor of gastric cancer prognosis: Incorporation into a nomogram
暂无分享,去创建一个
Fan Wang | Yong Li | B. Tan | Qun Zhao | L. Fan | Xüe-Feng Zhao | Dong Wang | Zhidong Zhang | Yu Liu | Dong Wang
[1] X. Zou,et al. Differential prognostic implications of gastric adenocarcinoma based on Lauren’s classification: a Surveillance, Epidemiology, and End Results (SEER)-based cohort study , 2021, Annals of translational medicine.
[2] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[3] Irene Abad,et al. "From Lauren's diffuse gastric cancer to WHO's poorly cohesive carcinoma." Clinicopathological and prognostic characteristics. , 2020 .
[4] M. Terashima,et al. Extra-nodal metastasis should be classified separately from lymph node metastasis in gastric cancer. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[5] Xiangqian Guo,et al. The Application of Deep Learning in Cancer Prognosis Prediction , 2020, Cancers.
[6] I. Bedrosian,et al. Importance of family history and indications for genetic testing , 2019, The breast journal.
[7] Zhimeng Xu,et al. Tumor deposit indicates worse prognosis than metastatic lymph node in gastric cancer: a propensity score matching study. , 2019, Annals of translational medicine.
[8] Andrew J. Vickers,et al. A simple, step-by-step guide to interpreting decision curve analysis , 2019, Diagnostic and Prognostic Research.
[9] H. Liang,et al. Impact of extranodal tumor deposits on prognosis and N stage in gastric cancer. , 2019, Surgery.
[10] Yue-xiang Liang,et al. Tumor Size Improves the Accuracy of the Prognostic Prediction of Lymph Node-Negative Gastric Cancer. , 2019, The Journal of surgical research.
[11] E. Jung,et al. Nomogram for predicting gastric cancer recurrence using biomarker gene expression. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[12] H. Hampel,et al. Recent Advances in Lynch Syndrome: Diagnosis, Treatment, and Cancer Prevention. , 2018, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[13] Y. K. Park,et al. Clinicopathological Features and Survival of Patients with Gastric Cancer with a Family History: a Large Analysis of 2,736 Patients with Gastric Cancer , 2017, Journal of gastric cancer.
[14] Wei Luo,et al. Guidelines for Developing and Reporting Machine Learning Predictive Models in Biomedical Research: A Multidisciplinary View , 2016, Journal of medical Internet research.
[15] K. Akazawa,et al. Nomogram for 5-year relapse-free survival of a patient with advanced gastric cancer after surgery. , 2016, International journal of surgery.
[16] L. Wood,et al. Extranodal Extension of Nodal Metastases Is a Poor Prognostic Indicator in Gastric Cancer: a Systematic Review and Meta-analysis , 2016, Journal of Gastrointestinal Surgery.
[17] Z. Long,et al. Prognostic significance of cancer family history for patients with gastric cancer: a single center experience from China , 2016, Oncotarget.
[18] Jeffrey W. Clark,et al. Familial Gastric Cancers. , 2015, The oncologist.
[19] Mithat Gonen,et al. Nomograms in oncology: more than meets the eye. , 2015, The Lancet. Oncology.
[20] Y. Nishino,et al. Family history, body mass index and survival in Japanese patients with stomach cancer: a prospective study , 2015, International journal of cancer.
[21] Muh-Hwa Yang,et al. Clinicopathological Variation of Lauren Classification in Gastric Cancer , 2015, Pathology & Oncology Research.
[22] W. Rubinstein,et al. American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Jin Hwa Kim,et al. Family history and survival of patients with gastric cancer: a meta-analysis. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[24] L. Bernstein,et al. Family history of cancer and gastroesophageal disorders and risk of esophageal and gastric adenocarcinomas: a case–control study , 2014, BMC Cancer.
[25] Chang-ming Huang,et al. Consideration of tumor size improves the accuracy of TNM predictions in patients with gastric cancer after curative gastrectomy. , 2013, Surgical oncology.
[26] A. Meloni-Ehrig,et al. Gastric cancer: Classification, histology and application of molecular pathology. , 2012, Journal of gastrointestinal oncology.
[27] Chang-ming Huang,et al. Analysis on the Clinical and Pathological Features and Prognosis of Familial Gastric Cancer in South China Population: A Single-Center Study of 724 Patients , 2012, Journal of oncology.
[28] I. Choi,et al. Association of family history with cancer recurrence and survival in patients with gastric cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] Sang Min Park,et al. Stomach cancer screening and preventive behaviors in relatives of gastric cancer patients. , 2011, World journal of gastroenterology.
[30] P. Lu,et al. Family history of cancer in Chinese gastric cancer patients , 2010 .
[31] S. Narod,et al. Family history and the risk of gastric cancer , 2009, British Journal of Cancer.
[32] N. Hu,et al. Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China , 2009, BMC Cancer.
[33] G. Raj,et al. How to build and interpret a nomogram for cancer prognosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] R. Wolff,et al. APC Mutations and Other Genetic and Epigenetic Changes in Colon Cancer , 2007, Molecular Cancer Research.
[35] R. Sinha,et al. Opportunities for cancer epidemiology in developing countries , 2004, Nature Reviews Cancer.
[36] S. Kitano,et al. Pathology and prognosis of gastric carcinoma , 2000, Cancer.